Tag : Aimmunes

Latest News

FDA approves Aimmune’s peanut allergy drug

Newsemia
Palforzia is the first drug to win approval to treat a food allergy. The approval follows a favorable, though not unanimous, vote by an FDA...
Latest News

FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug

Newsemia
The FDA’s Allergenic Products Advisory Committee voted 7-2 in favor of supporting the efficacy profile of Palforzia, or AR101. Some committee members expressed concerns about...
Latest News

FDA Allergenic Products Advisory Committee Votes to Support the Use of Aimmune’s PALFORZIA™ (AR101) for Peanut Allergy

Newsemia
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that the Allergenic Products Advisory Committee (APAC)...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy